Correction: Novel probiotic Lactobacillus helveticus WIS02 alleviates diabetes through multi-pronged regulation of glycolipid metabolism, pancreatic protection and gut microbiota remodeling
Shuang Guo, Yuying Li, Yanan Yang, Yuexiao Jiang, Yufeng Wang, Ying Cao, Yunfeng Duan, Chongming Wu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGut microbiota and health · Microbial Metabolites in Food Biotechnology · Probiotics and Fermented Foods
A correction has been made to Section 3.3 Lactobacillus helveticus QIS02 tends to favor the gut flora of diabetic animals, page 5, paragraph 2. The sentence “At the phylum level, At the door level….” Is a duplicate.
The corrected sentence appears below:
“At the phylum level, the DM group showed elevated levels of Proteobacteria and reduced levels of Firmicutes and Actinobacteria compared to the normal group.”
A correction has been made to 4 Discussion, page 9, paragraph 3. The sentence “Recent macro-genomics studies have revealed significant differences in the gut microbiota between healthy people and diabetic patients, suggesting that there is a significant association between the development of diabetes mellitus and the ecological dysregulation of gut microbiota [re].” contained a typo of the addition of “[re]”.
The corrected sentence appears below:
“Recent macro-genomics studies have revealed significant differences in the gut microbiota between healthy people and diabetic patients, suggesting that there is a significant association between the development of diabetes mellitus and the ecological dysregulation of gut microbiota.”
A correction has been made to Section 2.1 Preparation of bacterial suspensions, page 2, paragraph 1.
The corrected sentence appears below:
“Glycerol-preserved L. helveticus WIS02(CGMCC No. 29243) was provided by MGBlab, Microbiota-Gut-Brain Laboratory, WISBIOM (Bejing) Biotechnology Co. Ltd., and was retrieved from ultra-low temperature storage, thawed at room temperature, and incoculated into de Man-Rogosa-Sharpe (MRS) broth for anaerobic recovery at 37 °C.”
A correction has been made to Section 3.2 Lactobacillus helveticus WIS02 improves dyslipidemia in diabetic mice, page 5, paragraph 1. There were duplicated descriptions.
The corrected sentence appears below:
“STZ induction significantly elevated serum TC, TG, and LDL-C in the DM group compared to Norm mice.”
A correction has been made to Section 3.3 Lactobacillus helveticus WIS02 tends to favor the gut flora of diabetic animals, page 5, paragraph 3. There was a misspelling of Bacteroidetess.
The corrected sentence appears below:
“On the contrary, L. helveticus WIS02 treatment significantly decreased the abundance of Helicobacter cinaedi and increased the abundance of Bacteroidetes, especially Bacteroides caecimuris.”
The original version of this article has been updated.